A Comparative Evaluation of the New Genexpert MTB/RIF Ultra and other Rapid Diagnostic Assays for Detecting Tuberculosis in Pulmonary and Extra Pulmonary Specimens | Scientific Reports
PDF) Performance of the G4 Xpert® MTB/RIF assay for the detection of Mycobacterium tuberculosis and rifampin resistance: A retrospective case-control study of analytical and clinical samples from high- and low-tuberculosis prevalence settings
Discordant results of Xpert MTB/Rif assay and BACTEC MGIT 960 liquid culture to detect Mycobacterium tuberculosis in community screening in Vietnam | BMC Infectious Diseases | Full Text
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda - The Lancet Microbe
Patient classification, HIV prevalence and Xpert MTB/RIF Assay results... | Download Table
Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test - The Lancet Infectious Diseases
Results for MGIT culture and Xpert MTB/RIF for 6893 sputum specimens. | Download Table
The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing | mBio
Identification of Mycobacterium tuberculosis from pericardial fluid using the new Xpert MTB/RIF assay
Cepheid | MTB/RIF Molecular Test - Xpert MTB/RIF Ultra
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance | Future Microbiology
4.1.1 Decision pathway for Algorithm 1 – mWRD as the initial diagnostic test for TB | TB Knowledge Sharing
Ungoofaaru Regional Hospital on Twitter: "MTB Test run in GeneXpert Machine today. The GeneXpert MTB/RIF result is quicker & helps in selecting treatment regimens and reaching #TB control decisions quickly Thanks to @
Xpert MTB/Rif
Use of Xpert MTB/RIF and Xpert MTB/RIF Ultra on GeneXpert 10-colour instruments: WHO policy statement. Web Annex. Study report
Predictable repeatability issues with GeneXpert-Xpert MTB/RIF (version 4) derived rifampicin resistant tuberculosis results from South India: Appreciating the limits of a technological marvel! Sanker P, Kottuthodi RP, Ambika AP, Santhosh VT, Balakrishnan
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance | Future Microbiology
Development of dried tube specimens for Xpert MTB/RIF proficiency testing
GeneXpert introduction, procedure and its application - YouTube
Cepheid | MTB/RIF Molecular Test - Xpert MTB/RIF
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda. | Semantic Scholar
GeneXpert MTB/RIF Version G4 for Identification of Rifampin-Resistant Tuberculosis in a Programmatic Setting | Journal of Clinical Microbiology
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance | Future Microbiology
REPORT - Performance of Xpert MTB/RIF Version G4 assay
